Recent US Food and Drug Administration warnings on hepatitis B reactivation with immune-suppressing and anticancer drugs: Just the tip of the iceberg?-Reference-Cited by-全球学者库

Recent US Food and Drug Administration warnings on hepatitis B reactivation with immune-suppressing and anticancer drugs: Just the tip of the iceberg?

Published:2015-01-20 Issue:2 Volume:61 Page:703-711
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Di Bisceglie Adrian M.¹,Lok Anna S.²,Martin Paul³,Terrault Norah⁴,Perrillo Robert P.⁵,Hoofnagle Jay H.⁶

Affiliation:

1. Department of Internal Medicine; Saint Louis University School of Medicine; St. Louis MO

2. Division of Gastroenterology and Hepatology; University of Michigan; Ann Arbor MI

3. Univerisity of Miami; Miami FL

4. University of California-San Francisco; San Francisco CA

5. Baylor University Medical Center; Dallas TX

6. Liver Disease Research Branch; Division of Digestive Diseases and Nutrition, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health; Bethesda MD

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.27609/fullpdf

Reference27 articles.

1. US Food and Drug Administration Boxed warning and new recommendations to decrease risk of hepatitis B reactivation with the immune-suppressing and anti-cancer drugs Arzerra (ofatumumab) and Rituxan (rituximab). Drug Safety Communications http://www.fda.gov/downloads/Drugs/DrugSafety/UCM369436.pdf 2013

2. Recommendations for identification and public health management of persons with chronic hepatitis B virus infection;Weinbaum;MMWR Recomm Rep,2008

3. Systematic review: The effect of preventive lamivudine on hepatitis B reactivation during chemotherapy;Loomba;Ann Intern Med,2008

4. Immune effectors required for hepatitis B virus clearance;Yang;Proc Natl Acad Sci USA,2010

5. Reactivation of hepatitis B;Hoofnagle;Hepatology,2009

Cited by 198 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Managing HBV and HCV Infection Pre- and Post-liver Transplant;Journal of Clinical and Experimental Hepatology;2024-03

2. Lymphocytes and Infection in Autoimmune Diseases;Infection and Autoimmunity;2024

3. Corydalis and Drug-Induced Liver Injury: A Series of 2 Cases;ACG Case Reports Journal;2023-12

4. HBV reactivation in HBsAg−/HBcAb+ rheumatoid arthritis patients receiving biologic/targeted synthetic DMARDs;Liver International;2023-11-27

5. Risk of Hepatitis B Virus Reactivation in Patients with Resolved Infection on Therapy with Corticosteroids and Conventional Synthesis Immunosuppressants for Kidney Disease: A Single-Center Analysis of 258 Patients;The Turkish Journal of Gastroenterology;2023-10-03